{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:11:05Z","timestamp":1790417465665,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Scientist Development Grant","doi-asserted-by":"publisher","award":["16SDG30170026"],"award-info":[{"award-number":["16SDG30170026"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.actbio.2019.07.012","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T20:09:57Z","timestamp":1562875797000},"page":"537-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Resurrection of antibiotics that methicillin-resistant Staphylococcus aureus resists by silver-doped bioactive glass-ceramic microparticles"],"prefix":"10.1016","volume":"96","author":[{"given":"Natalia","family":"Pajares-Chamorro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal D.","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xanthippi","family":"Chatzistavrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2019.07.012_b0005","unstructured":"CDC Office of Infectious Diseases, Centers for Disease Control and Prevention, Antibiotic resistance threats in the United States, 2013, 2013. doi:CS239559-B."},{"key":"10.1016\/j.actbio.2019.07.012_b0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/35021219","article-title":"Molecular mechanisms that confer antibacterial drug resistance","volume":"406","author":"Walsh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2019.07.012_b0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2009.08.001","article-title":"The clinical consequences of antimicrobial resistance","volume":"12","author":"Rice","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1099\/00222615-44-3-157","article-title":"Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections","volume":"44","author":"Cunningham","year":"1996","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2019.07.012_b0030","article-title":"Experimental osteomyelitis. I. A description of the model","volume":"122","author":"Norden","year":"1970","journal-title":"J. Infect. Dis. @BULLET."},{"key":"10.1016\/j.actbio.2019.07.012_b0035","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/iai.64.7.2371-2380.1996","article-title":"Bacterially induced bone destruction: mechanisms and misconceptions","volume":"64","author":"Nair","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2019.07.012_b0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/589241","article-title":"Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers","volume":"47","author":"Datta","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actbio.2019.07.012_b0045","unstructured":"N. Asghar, M. Asghar, S. Mumtaz, A. Hussain, Material and methods data collection procedure, 9 (2016) 316."},{"key":"10.1016\/j.actbio.2019.07.012_b0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actbio.2019.07.012_b0055","unstructured":"European Centre for Disease Prevention and Control, The bacterial challenge: time to react, (2009). doi:10.2900\/2518."},{"key":"10.1016\/j.actbio.2019.07.012_b0060","doi-asserted-by":"crossref","unstructured":"The Council of the European Union, Council Recommendation of 9 June 2009 on patient safety, including the prevention and control of healthcare associated infections, Off. J. Eur. Union. (2009). doi:10.1097\/HCR.0b013e31823be0bc.","DOI":"10.1097\/HCR.0b013e31823be0bc"},{"key":"10.1016\/j.actbio.2019.07.012_b0065","article-title":"CO-MRSA infections in australia cost $3.5B per annum","author":"Cameron","year":"2017","journal-title":"Fac. Heal. Inst. Heal. Biomed. Innov."},{"key":"10.1016\/j.actbio.2019.07.012_b0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.actbio.2019.07.012_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2014.10.027","article-title":"Therapeutic strategies to combat antibiotic resistance","author":"Brooks","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.07.012_b0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/femsre\/fux007","article-title":"Antibiotic resistance in Staphylococcus aureus. Current status and future prospects","volume":"41","author":"Foster","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.actbio.2019.07.012_b0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","article-title":"\u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era","volume":"156","author":"Huh","year":"2011","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actbio.2019.07.012_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro2133","article-title":"Drug interactions and the evolution of antibiotic resistance","author":"Yeh","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0805965105","article-title":"Accelerated evolution of resistance in multidrug environments","author":"Hegreness","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2019.07.012_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001540","article-title":"When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition","author":"Pena-Miller","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.actbio.2019.07.012_b0105","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2012.0279","article-title":"The optimal deployment of synergistic antibiotics: a control-theoretic approach","author":"Pe\u00f1a-Miller","year":"2012","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.actbio.2019.07.012_b0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0037-1602715","article-title":"New strategies targeting virulence factors of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"38","author":"Fran\u00e7ois","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.actbio.2019.07.012_b0115","doi-asserted-by":"crossref","first-page":"v","DOI":"10.1016\/j.mib.2017.11.025","article-title":"Editorial overview: antimicrobials","volume":"39","author":"Mueller","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","article-title":"Combination therapies for combating antimicrobial resistance","volume":"14","author":"Fischbach","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nchembio.1911","article-title":"Synergistic, collaterally sensitive \u03b2-lactam combinations suppress resistance in MRSA","volume":"11","author":"Gonzales","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.actbio.2019.07.012_b0130","article-title":"Combinatory antibiotic therapy increases rate of bacterial kill but not final outcome in a novel mouse model of Staphylococcus aureus spinal implant infection","volume":"12","author":"Hu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2019.07.012_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","author":"Levy","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2019.07.012_b0140","doi-asserted-by":"crossref","DOI":"10.2165\/00003495-200262040-00001","article-title":"Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium","author":"Sefton","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.actbio.2019.07.012_b0145","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.arcmed.2005.06.009","article-title":"Resistance to antibiotics: are we in the post-antibiotic era?","volume":"36","author":"Alanis","year":"2005","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.actbio.2019.07.012_b0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micres.2014.08.003","article-title":"The effect of metal ions on Staphylococcus aureus revealed by biochemical and mass spectrometric analyses","volume":"170","author":"Chudobova","year":"2015","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.actbio.2019.07.012_b0155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/polym3010340","article-title":"New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles","volume":"3","author":"Knetsch","year":"2011","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.actbio.2019.07.012_b0160","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.07.012_b0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.actbio.2017.06.046","article-title":"Multifunctional bioactive glass and glass-ceramic biomaterials with antibacterial properties for repair and regeneration of bone tissue","volume":"59","author":"Fernandes","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.07.012_b0170","doi-asserted-by":"crossref","DOI":"10.1007\/s10856-012-4580-z","article-title":"Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review, in","author":"Hum","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.actbio.2019.07.012_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006276","article-title":"Silver enhances antibiotic activity against Gram-negative bacteria","volume":"5","author":"Morones-Ramirez","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2019.07.012_b0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biomaterials.2016.06.004","article-title":"Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections","volume":"101","author":"Wang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.07.012_b0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.nano.2007.02.001","article-title":"Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli","volume":"3","author":"Shahverdi","year":"2007","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.actbio.2019.07.012_b0190","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.biomaterials.2012.09.066","article-title":"Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity","volume":"34","author":"Wu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.07.012_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2014.04.026","article-title":"Multifunctional mesoporous bioactive glasses for effective delivery of therapeutic ions and drug\/growth factors","volume":"193","author":"Wu","year":"2014","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actbio.2019.07.012_b0200","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1039\/C0DT01390K","article-title":"Preparation of luminescent and mesoporous Eu 3+ \/Tb 3+ doped calcium silicate microspheres as drug carriers via a template route","volume":"40","author":"Kang","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.actbio.2019.07.012_b0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.msec.2017.11.003","article-title":"Mesoporous silica-based bioactive glasses for antibiotic-free antibacterial applications","volume":"83","author":"Kaya","year":"2018","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.actbio.2019.07.012_b0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crci.2009.03.004","article-title":"Evolution of bioceramics within the field of biomaterials","volume":"13","author":"Vallet-Reg\u00ed","year":"2010","journal-title":"C. R. Chim."},{"key":"10.1016\/j.actbio.2019.07.012_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.09.052","article-title":"Mesoporous bioactive glasses: Promising platforms for antibacterial strategies","volume":"81","author":"Kargozar","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.07.012_b0220","doi-asserted-by":"crossref","unstructured":"L. Drago, D. Roman\u00f2, E. De Vecchi, C. Vassena, N. Logoluso, R. Mattina, C.L. Roman\u00f2, Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study, 2013.","DOI":"10.1186\/1471-2334-13-584"},{"key":"10.1016\/j.actbio.2019.07.012_b0225","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2010.05.030","article-title":"Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis","volume":"47","author":"Lindfors","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2019.07.012_b0230","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1557\/jmr.2012.375","article-title":"Evaluation of Ti implants coated with Ag-containing borate bioactive glass for simultaneous eradication of infection and fracture fixation in a rabbit tibial model","volume":"27","author":"Xiao","year":"2012","journal-title":"J. Mater. Res."},{"key":"10.1016\/j.actbio.2019.07.012_b0235","doi-asserted-by":"crossref","DOI":"10.1557\/opl.2012.743","article-title":"Development of new sol-gel derived Ag-doped biomaterials for dental applications","volume":"1417","author":"Chatzistavrou","year":"2012","journal-title":"MRS Proc."},{"key":"10.1016\/j.actbio.2019.07.012_b0240","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1016\/j.actbio.2014.04.030","article-title":"Fabrication and characterization of bioactive and antibacterial composites for dental applications","volume":"10","author":"Chatzistavrou","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.07.012_b0245","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.msec.2010.03.005","article-title":"Sol-gel based fabrication of novel glass-ceramics and composites for dental applications","volume":"30","author":"Chatzistavrou","year":"2010","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.actbio.2019.07.012_b0250","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/j.jeurceramsoc.2012.04.037","article-title":"Sol-gel based fabrication and characterization of new bioactive glass-ceramic composites for dental applications","volume":"32","author":"Chatzistavrou","year":"2012","journal-title":"J. Eur. Ceram. Soc."},{"key":"10.1016\/j.actbio.2019.07.012_b0255","doi-asserted-by":"crossref","unstructured":"S.K. Misra, T. Ansari, D. Mohn, S.P. Valappil, T.J. Brunner, W.J. Stark, I. Roy, J.C. Knowles, P.D. Sibbons, E.V. Jones, A.R. Boccaccini, V. Salih, Effect of nanoparticulate bioactive glass particles on bioactivity and cytocompatibility of poly(3-hydroxybutyrate) composites, (n.d.). doi: 10.1098\/rsif.2009.0255.","DOI":"10.1098\/rsif.2009.0255"},{"key":"10.1016\/j.actbio.2019.07.012_b0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jbm.b.31392","article-title":"In vitro\/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(\u03b5-caprolactone) composite materials","volume":"91B","author":"Jo","year":"2009","journal-title":"J. Biomed. Mater. Res. Part B: Appl. Biomater."},{"key":"10.1016\/j.actbio.2019.07.012_b0265","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1248\/bpb.22.1388","article-title":"Marked reduction in the minimum inhibitory concentration (MIC) of beta-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis)","volume":"22","author":"Shiota","year":"1999","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.actbio.2019.07.012_b0270","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/AAC.43.2.421","volume":"43","author":"Jones","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2019.07.012_b0275","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actbio.2019.07.012_b0280","doi-asserted-by":"crossref","first-page":"e00537","DOI":"10.1128\/mBio.00537-12","article-title":"A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes","volume":"4","author":"Fey","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.actbio.2019.07.012_b0285","article-title":"Principles and techniques of electron microscopy. Biological applications","author":"Hayat","year":"1981","journal-title":"Princ. Tech. Electron Microsc. Biol. Appl."},{"key":"10.1016\/j.actbio.2019.07.012_b0290","unstructured":"K.L. Klomparens, S.L. Flegler, G.R. Hooper, G.R. Hooper, Procedures for transmission and scanning electron microscopy for biological and medical science (1986)."},{"key":"10.1016\/j.actbio.2019.07.012_b0295","series-title":"Antibiotics: Challenges, Mechanisms, Opportunities","author":"Walsh","year":"2016"},{"key":"10.1016\/j.actbio.2019.07.012_b0300","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1749-6632.1974.tb43277.x","article-title":"The mechanism of action of fosfomycin (phosphonomycin)","volume":"235","author":"Kahan","year":"1974","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.actbio.2019.07.012_b0305","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved glycopeptide antibacterial drugs: mechanism of action and resistance","volume":"6","author":"Zeng","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.actbio.2019.07.012_b0310","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11274-009-0211-3","article-title":"Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria","volume":"26","author":"Lara","year":"2010","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.actbio.2019.07.012_b0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jnoncrysol.2015.03.024","article-title":"Collagen\/fibrin microbeads as a delivery system for Ag-doped bioactive glass and DPSCs for potential applications in dentistry","volume":"432","author":"Chatzistavrou","year":"2016","journal-title":"J. Non. Cryst. Solids"},{"key":"10.1016\/j.actbio.2019.07.012_b0320","first-page":"1087","article-title":"Antimicrobial macroporous gel-glasses: dissolution and cytotoxicity","volume":"254\u2013256","author":"Saravanapavan","year":"2004","journal-title":"Key Eng. Mater."},{"key":"10.1016\/j.actbio.2019.07.012_b0325","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1128\/AEM.71.11.7589-7593.2005","article-title":"Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis","volume":"71","author":"Yamanaka","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/10408449609012524","article-title":"Toxicological aspects of topical silver pharmaceuticals","volume":"26","author":"Hollinger","year":"1996","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.actbio.2019.07.012_b0335","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1128\/AAC.46.6.1940-1945.2002","article-title":"Broad-spectrum bactericidal activity of Ag2 O-doped bioactive glass broad-spectrum bactericidal activity of Ag2 O-doped bioactive glass","volume":"46","author":"Bellantone","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2019.07.012_b0340","doi-asserted-by":"crossref","first-page":"342","DOI":"10.22203\/eCM.v029a26","article-title":"Biological and bactericidal properties of Ag-doped bioactive glass in a natural extracellular matrix hydrogel with potential application in dentistry","volume":"29","author":"Wang","year":"2015","journal-title":"Eur. Cells Mater."},{"key":"10.1016\/j.actbio.2019.07.012_b0345","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jcis.2004.02.012","article-title":"Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria","volume":"275","author":"Sondi","year":"2004","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.actbio.2019.07.012_b0350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/000163598422901","article-title":"Antibacterial effects of a bioactive glass paste on oral microorganisms","volume":"56","author":"Stoor","year":"1998","journal-title":"Acta Odontol. Scand."},{"key":"10.1016\/j.actbio.2019.07.012_b0355","doi-asserted-by":"crossref","DOI":"10.1111\/j.1541-4337.2004.tb00057.x","article-title":"Adaptation of Microorganisms to Cold Temperatures, Weak Acid Preservatives, Low pH, and Osmotic Stress: A Review","author":"Beales","year":"2004","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.actbio.2019.07.012_b0360","first-page":"1S","article-title":"The truth about silver","volume":"50","author":"Ovington","year":"2004","journal-title":"Ostomy. Wound. Manage."},{"key":"10.1016\/j.actbio.2019.07.012_b0365","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3390\/ma6062295","article-title":"Mechanisms of silver nanoparticle release, transformation and toxicity: a critical review of current knowledge and recommendations for future studies and applications","volume":"6","author":"Reidy","year":"2013","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.actbio.2019.07.012_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1078\/0944-5013-00069","article-title":"A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi","volume":"156","author":"Hamouda","year":"2001","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.actbio.2019.07.012_b0375","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1128\/AAC.46.8.2668-2670.2002","article-title":"Chemiosmotic mechanism of antimicrobial activity of Ag(+) in Vibrio cholerae","volume":"46","author":"Dibrov","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2019.07.012_b0380","doi-asserted-by":"crossref","unstructured":"C.-N. Lok, C.-M. Ho, R. Chen, Q.-Y. He, W.-Y. Yu, H. Sun, P.K.-H. Tam, A. Jen-Fu Chiu, C.-M. Che, Proteomic analysis of the mode of antibacterial action of silver nanoparticles, (2006). doi: 10.1021\/PR0504079.","DOI":"10.1021\/pr0504079"},{"key":"10.1016\/j.actbio.2019.07.012_b0385","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10534-010-9381-6","article-title":"Antibacterial effect of silver nanoparticles on Staphylococcus aureus","volume":"24","author":"Li","year":"2011","journal-title":"BioMetals"},{"key":"10.1016\/j.actbio.2019.07.012_b0390","series-title":"The Bacterial RecA Protein: Structure, Function, and Regulation","first-page":"53","author":"Cox","year":"2007"},{"key":"10.1016\/j.actbio.2019.07.012_b0395","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/AEM.69.7.4278-4281.2003","article-title":"Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate","volume":"69","author":"Matsumura","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0400","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/AEM.02001-07","article-title":"Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli","volume":"74","author":"Jung","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0405","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/AAC.01830-09","article-title":"Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction","volume":"54","author":"Gordon","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2019.07.012_b0410","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1088\/0957-4484\/16\/10\/059","article-title":"The bactericidal effect of silver nanoparticles","volume":"16","author":"Morones","year":"2005","journal-title":"Nanotechnology."},{"key":"10.1016\/j.actbio.2019.07.012_b0415","article-title":"Antibacterial characterization of silver nanoparticles against","volume":"24","author":"Raffi","year":"2008","journal-title":"J. Mater. Sci. Technol."},{"key":"10.1016\/j.actbio.2019.07.012_b0420","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nano.2006.12.001","article-title":"Antimicrobial effects of silver nanoparticles","volume":"3","author":"Kim","year":"2007","journal-title":"Nanomedicine."},{"key":"10.1016\/j.actbio.2019.07.012_b0425","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3","article-title":"A mechanistic study of the antibacterial effect of silver ion on Escherichia coli and Staphylococcus aureus","volume":"52","author":"Feng","year":"2000","journal-title":"J Biomed Mater Res."},{"key":"10.1016\/j.actbio.2019.07.012_b0430","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrmicro3088","article-title":"How to get (a)round: mechanisms controlling growth and division of coccoid bacteria","volume":"11","author":"Pinho","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actbio.2019.07.012_b0435","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.28.5.689","article-title":"In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus","volume":"28","author":"Alvarez","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2019.07.012_b0440","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1055\/s-2008-1070908","article-title":"Comparison of activity of fosfomycin, oxacillin and penicillin G against staphylococci and micrococci (author\u2019s transl)","volume":"105","author":"Peters","year":"1980","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.actbio.2019.07.012_b0445","doi-asserted-by":"crossref","unstructured":"S. Eschenburg, M. Priestman, E. Sch\u00f6, Evidence that the fosfomycin target Cys 115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release*, (2004). doi: 10.1074\/jbc.M411325200.","DOI":"10.1074\/jbc.M411325200"},{"key":"10.1016\/j.actbio.2019.07.012_b0450","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1039\/NP9961300469","article-title":"The glycopeptide story \u2013 how to kill the deadly \u2018superbugs\u2019","volume":"13","author":"Williams","year":"1996","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.actbio.2019.07.012_b0455","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2019.07.012_b0460","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3923\/ijp.2013.150.156","article-title":"Electron microscope study of gall extract from quercus infectoria in combination with vancomycin against mrsa using post-antibiotic effect determination","volume":"9","author":"Basri","year":"2013","journal-title":"Int. J. Pharmacol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119304921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119304921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:24:45Z","timestamp":1761672285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119304921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":92,"alternative-id":["S1742706119304921"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.07.012","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resurrection of antibiotics that methicillin-resistant Staphylococcus aureus resists by silver-doped bioactive glass-ceramic microparticles","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}